Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bupivacaine hydrochloride 0.1% infusion solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 0.125% infusion solution 250mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 0.75% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 0.1% infusion solution 100 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 0.1% infusion solution 250 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride+fentanyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride+fentanyl 0.1%/2micrograms/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 5mg/epinephrine 5mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 2.5mg/epinephrine bitartrate 5mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 0.5%/epinephrine 50micrograms 10mL (1:200000) injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride 7.5mg/dextrose 82.5mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride monohydrate (substance) |
Is a |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely bupivacaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 25 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 25 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 1.25 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 1.25 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|